United States (US) Acute Myeloid Testing Market (2025-2031) | Companies, Size & Revenue, Industry, Analysis, Share, Value, Segmentation, Competitive Landscape, Growth, Forecast, Trends, Outlook

Name: United States (US) Acute Myeloid Testing Market (2025-2031) | Companies & Size
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Biomarker Type (Proteomic AML Biomarker, Genetic AML Biomarker, Epigenetic AML Biomarker), By Product and Service (Services, Assay Kits), By Technology (PCR, IHC, NGS, Cytogenetics, Others), By End User (Clinical Laboratories, Hospitals, Academic and Research Institutes, Cancer Diagnostic Institutes) And Competitive Landscape

Product Code: ETC9958581	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Sumit Sagar	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Acute Myeloid Testing Market Outlook
Market Size of United States (US) Acute Myeloid Testing Market, 2024
Forecast of United States (US) Acute Myeloid Testing Market, 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Revenues & Volume for the Period 2021- 2031
United States (US) Acute Myeloid Testing Market Trend Evolution
United States (US) Acute Myeloid Testing Market Drivers and Challenges
United States (US) Acute Myeloid Testing Price Trends
United States (US) Acute Myeloid Testing Porter's Five Forces
United States (US) Acute Myeloid Testing Industry Life Cycle
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Biomarker Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Proteomic AML Biomarker for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Genetic AML Biomarker for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Epigenetic AML Biomarker for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Product and Service for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Services for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Assay Kits for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Technology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By PCR for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By IHC for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By NGS for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Cytogenetics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By End User for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Clinical Laboratories for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Academic and Research Institutes for the Period 2021- 2031
Historical Data and Forecast of United States (US) Acute Myeloid Testing Market Revenues & Volume By Cancer Diagnostic Institutes for the Period 2021- 2031
United States (US) Acute Myeloid Testing Import Export Trade Statistics
Market Opportunity Assessment By Biomarker Type
Market Opportunity Assessment By Product and Service
Market Opportunity Assessment By Technology
Market Opportunity Assessment By End User
United States (US) Acute Myeloid Testing Top Companies Market Share
United States (US) Acute Myeloid Testing Competitive Benchmarking By Technical and Operational Parameters
United States (US) Acute Myeloid Testing Company Profiles
United States (US) Acute Myeloid Testing Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Acute Myeloid Testing Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Acute Myeloid Testing Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Acute Myeloid Testing Market - Industry Life Cycle

3.4 United States (US) Acute Myeloid Testing Market - Porter's Five Forces

3.5 United States (US) Acute Myeloid Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F

3.6 United States (US) Acute Myeloid Testing Market Revenues & Volume Share, By Product and Service, 2021 & 2031F

3.7 United States (US) Acute Myeloid Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.8 United States (US) Acute Myeloid Testing Market Revenues & Volume Share, By End User, 2021 & 2031F

4 United States (US) Acute Myeloid Testing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of acute myeloid leukemia (AML) in the US

4.2.2 Technological advancements in testing methods for AML

4.2.3 Rising awareness and early diagnosis initiatives for AML

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of AML testing methods

4.3.2 High cost associated with advanced AML testing technologies

5 United States (US) Acute Myeloid Testing Market Trends

6 United States (US) Acute Myeloid Testing Market, By Types

6.1 United States (US) Acute Myeloid Testing Market, By Biomarker Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Biomarker Type, 2021- 2031F

6.1.3 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Proteomic AML Biomarker, 2021- 2031F

6.1.4 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Genetic AML Biomarker, 2021- 2031F

6.1.5 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Epigenetic AML Biomarker, 2021- 2031F

6.2 United States (US) Acute Myeloid Testing Market, By Product and Service

6.2.1 Overview and Analysis

6.2.2 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Services, 2021- 2031F

6.2.3 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Assay Kits, 2021- 2031F

6.3 United States (US) Acute Myeloid Testing Market, By Technology

6.3.1 Overview and Analysis

6.3.2 United States (US) Acute Myeloid Testing Market Revenues & Volume, By PCR, 2021- 2031F

6.3.3 United States (US) Acute Myeloid Testing Market Revenues & Volume, By IHC, 2021- 2031F

6.3.4 United States (US) Acute Myeloid Testing Market Revenues & Volume, By NGS, 2021- 2031F

6.3.5 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Cytogenetics, 2021- 2031F

6.3.6 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Acute Myeloid Testing Market, By End User

6.4.1 Overview and Analysis

6.4.2 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F

6.4.3 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.4 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F

6.4.5 United States (US) Acute Myeloid Testing Market Revenues & Volume, By Cancer Diagnostic Institutes, 2021- 2031F

7 United States (US) Acute Myeloid Testing Market Import-Export Trade Statistics

7.1 United States (US) Acute Myeloid Testing Market Export to Major Countries

7.2 United States (US) Acute Myeloid Testing Market Imports from Major Countries

8 United States (US) Acute Myeloid Testing Market Key Performance Indicators

8.1 Average turnaround time for AML test results

8.2 Adoption rate of next-generation sequencing (NGS) technology in AML testing

8.3 Number of research and development collaborations for innovative AML testing solutions

9 United States (US) Acute Myeloid Testing Market - Opportunity Assessment

9.1 United States (US) Acute Myeloid Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F

9.2 United States (US) Acute Myeloid Testing Market Opportunity Assessment, By Product and Service, 2021 & 2031F

9.3 United States (US) Acute Myeloid Testing Market Opportunity Assessment, By Technology, 2021 & 2031F

9.4 United States (US) Acute Myeloid Testing Market Opportunity Assessment, By End User, 2021 & 2031F

10 United States (US) Acute Myeloid Testing Market - Competitive Landscape

10.1 United States (US) Acute Myeloid Testing Market Revenue Share, By Companies, 2024

10.2 United States (US) Acute Myeloid Testing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Acute Myeloid Testing Market

Estonia Acute Myeloid Testing Market

Ethiopia Acute Myeloid Testing Market

Fiji Acute Myeloid Testing Market

Finland Acute Myeloid Testing Market

Gabon Acute Myeloid Testing Market

Global Acute Myeloid Testing Market

Middle East Acute Myeloid Testing Market

North America Acute Myeloid Testing Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here